Related Experiment Video
Updated: Dec 9, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Inflammatory Myofibroblastic Tumour
Pedro Pimentel Duarte1, Rafaela Sousa1, Mariana Chaves1
1Hospital do Divino Espirito Santo de Ponta Delgada, Ponta Delgada, Portugal.
Abstract:
Inflammatory myofibroblastic tumour (IMT) is a rare mesenchymal tumour. It is usually benign but may behave as a malignant tumour with multiple recurrences and metastases. We present the case of a young woman with weight loss associated with diffuse abdominal pain, who was shown to have a large pancreatic mass. Investigation revealed fusocellular mesenchymal neoplasia, compatible with the diagnosis of IMT. As the mass was unresectable, glucocorticoid therapy was initiated with an excellent response and regression of the tumour.
Learning Points:
Inflammatory myofibroblastic tumour (IMT) is a rare entity.Since IMT can occur in different locations, its clinical presentation is varied, with non-specific symptoms.Prognosis is usually benign, but relapse and metastasis have been reported.
Related Concept Videos
The Tumor Microenvironment
Introduction to Fibroblasts
Abnormal Proliferation
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests

